This suggests different regulatory mechanisms may be applicable between TIMP-1 and IL-6 expression depending upon elements present within various cell types or cancer specific tumor microenvironments, and our results may be specific to this interaction within NSCLC. The gene discussed is TIMP1; the disease is non-small cell lung carcinoma.